PLD2 and Familial prostate cancer: The data were similar to the findings in glioblastoma and prostate cancer, in which miR-203 was down-regulated, and ectopic expression of miR-203 suppressed cell proliferation and induced a G1-phase arrest by targeting PLD2 [20].